October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA), will now become…
Invitational Conference on Drug User Activism International Drug User Day 2003, October 31st/November 1st Copenhagen, Denmark The Danish Drug Users Union – BrugerForeningen and the Dutch National Interest Group of Drug Users – Landelijk Steunpunt Druggebruikers sponsor “Moving Forward” a meeting on drug user activism. The gathering was to mark both the International Drug User…
Congratulations to Sara Gefvert, the 2022 Lane/Holden Award Winner! November 2, 2022 The 2022 Richard Lane/Robert Holden Patient Advocacy Award was presented at an Awards Reception held in conjunction with the 2022 Conference of the American Association for the Treatment of Opioid Dependence (AATOD) in Baltimore, Maryland on November 2, 2022. Richard Lane/Robert Holden Patient…
The Writer Asks to Have Their Name Withheld for Fear of Retaliation Imagine — a young woman is in the Ladies Room stall, the Door is being held open by a worker whose job it is to observe the woman (any female patient) give a urine sample. This sample is tested for any drugs that…
Methadone Advocacy The National Alliance of Methadone Advocates (NAMA) holds the view that every individual who believes in methadone treatment is at least a potential Certified Methadone Advocate (CMA). We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates so that all energies directed toward the advancement of methadone treatment…
